Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “Multiple sclerosis”
Prebiotic vs Probiotic in Multiple Sclerosis
ClinicalTrials.gov study NCT04038541. IPD Sharing: NO. Countries: 1. Publications: 0.
The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00917839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)
ClinicalTrials.gov study NCT02408380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Application of ihMT MRI in Multiple Sclerosis
ClinicalTrials.gov study NCT03600779. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT01310166. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.
ClinicalTrials.gov study NCT05777902. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT05767736. IPD Sharing: YES. Countries: 1. Publications: 0.
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
ClinicalTrials.gov study NCT02967380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS
ClinicalTrials.gov study NCT03979456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exercise in Multiple Sclerosis
ClinicalTrials.gov study NCT02716701. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT06433765. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00200655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mood Disorders in Multiple Sclerosis Patients
ClinicalTrials.gov study NCT06652308. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effects of Two Types of t-DCS Stimulation on Robot-assisted Gait Training in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT06121635. IPD Sharing: NO. Countries: 1. Publications: 0.
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT07189325. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
ClinicalTrials.gov study NCT02099370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia
ClinicalTrials.gov study NCT07168694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea
ClinicalTrials.gov study NCT01071694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT00811902. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients
ClinicalTrials.gov study NCT02142764. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.